UNITED ~~STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549~~STATES

~~––––––––––––––––––––––––––––––––––~~SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

~~––––––––––––––––––––––––––––––––––~~REPORT OF FOREIGN PRIVATE ISSUER

~~REPORT~~Pursuant OFto ~~FOREIGN~~Rule ~~PRIVATE ISSUERPURSUANT TO RULE~~ 13a-16 OR or 15d-~~16UNDER~~16 ~~THE~~under ~~SECURITIES~~the Securities ~~EXCHANGE~~Exchange ~~ACT~~Act OFof 1934

For the month of August 2025

Commission File Number: 001-41425

~~––––––––––––––––––––––––––––––––––~~金太阳健康科技集团有限公司

~~Golden Sun Health Technology Group Limited金太阳健康科技集团有限公司~~(Translation of registrant’s name into English)

~~––––––––––––––––––––––––––––––––––~~Golden Sun Health Technology Group Limited

Room 503, Building C2, No. ~~1599Xinjinqiao Road, Pudong New AreaShanghai, China(Address of principal executive office)~~1599

~~––––––––––––––––––––––––––––––––––~~Xinjinqiao Road, Pudong New Area

~~Indicate~~Shanghai, ~~by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:~~China

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒ Form 40-F ☐

INCORPORATION BY REFERENCE

This Current Report on Form 6-K shall be deemed to be incorporated by reference into the registration statement on Form F-1, as amended (Registration Number: 333-285857) of Golden Sun Health Technology Group Limited, a Cayman Islands exempted company (the “Company”), declared effective by the Securities and Exchange Commission (“SEC”) on March 25, 2025 (“Registration Statement”), and into each prospectus or prospectus supplement outstanding under the Registration Statement, to the extent not superseded by documents or reports subsequently filed or furnished by the Company under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended.

INFORMATION CONTAINED IN THIS FORM 6-K REPORT

~~The~~As ~~extraordinary~~previously ~~general~~reported ~~meeting~~in ofthe ~~holders~~Current ofReport ~~Class A~~on Form ~~ordinary~~6-K ~~shares~~filed ofwith ~~Golden~~the ~~Sun~~SEC ~~Health~~on ~~Technology~~December ~~Group~~6, ~~Limited~~2024 (“December 2024 6-K”), pursuant to a ~~company~~certain ~~incorporated~~Securities ~~under~~Purchase Agreement (the ~~laws~~“SPA”), ofdated October 28, 2024, entered into by and between the ~~Cayman~~Company ~~Islands~~and two accredited investors (the “~~Company~~Investors”), the ~~will~~Company behas ~~held~~issued onand ~~September 25,~~sold ~~2025,~~to ~~followed~~the byInvestors ~~the~~i) ~~2025~~a ~~annual~~Convertible ~~general~~Note ~~meeting~~(the of“Note”) ~~shareholders~~in the aggregate principal amount of ~~the~~$5,000,000 ~~Company~~and ~~(together~~ii) ~~with~~a Warrant (the ~~extraordinary~~“Warrant”) ~~general~~to ~~meeting~~purchase ofan ~~holders~~amount of Class A ordinary shares, $0.005 par value per share, (the “~~Meetings~~Class A Ordinary Shares”). Inof ~~connection~~the ~~with~~Company as calculated in accordance per the ~~Meetings~~SPA, at the ~~Company~~closing held ~~hereby~~on ~~furnishes~~December ~~the~~3, ~~following documents:~~2024.

~~Attached~~As aspreviously ~~Exhibit~~reported ~~99.1~~in tothe ~~this~~Current Report ~~are~~on Form 6-K filed with the ~~Combined~~SEC ~~Notice~~February ~~and~~28, ~~Proxy~~2025, ~~Statement~~the Company received a written notification from the staff (the “Staff”) of the ~~Extraordinary~~Nasdaq ~~General~~Capital ~~Meeting~~Market ofLLC ~~holders~~(“Nasdaq”), ofdated ~~Class A~~February ~~ordinary~~24, ~~shares~~2025, ofthat the Company ~~and~~does ~~the~~not ~~2025~~meet ~~Annual~~the ~~General~~minimum ~~Meeting~~shareholders’ equity of ~~holders~~$2.5 ofmillion ~~ordinary~~under ~~shares~~the ofNasdaq Listing Rule 5550(b)(1) (the “Shareholder Equity Rule”) for continued listing. The Company, ~~dated~~subsequently ~~August 15,~~submitted ~~2025,~~a toplan befor ~~mailed~~compliance to ~~holders~~the ofStaff ~~Class A~~to ~~ordinary~~regain ~~shares~~compliance ofwith the ~~Company~~Shareholder Equity Rule.

~~Attached~~On asAugust ~~Exhibit~~22, ~~99.2~~2025, tothe ~~this~~Investors ~~Report~~fully exercised is the ~~Notice~~Warrant and ~~Proxy~~converted ~~Statement~~all ofoutstanding ~~the~~principal ~~2025~~and ~~Annual~~interest ~~General~~under ~~Meeting~~the ofNote ~~holders~~into ofClass ~~ordinary~~A ~~shares~~Ordinary ~~of the Company~~Shares, ~~dated~~resulting ~~August 15,~~in the ~~2025,~~issuance toof bean ~~mailed~~aggregate to6,747,926 ~~holders of~~ Class B ~~ordinary~~A ~~shares~~Ordinary ofShares ~~the~~to ~~Company~~such Investors.

~~Attached~~As assuch, ~~Exhibit~~the ~~99.3~~Note toand ~~this~~the ~~Report~~Warrant isare ~~Form~~no longer outstanding. The carrying value of ~~Proxy~~the ~~Card~~Note toand bethe ~~mailed~~Warrant, towith ~~holders~~an aggregated amount of ~~Class A~~approximately ~~ordinary~~$9.4 ~~shares~~million as of March 31, 2025, will be reclassified to the Company’s ~~for~~total ~~use~~equity inas ~~connection~~of ~~with~~August 25, 2025. Therefore, the ~~Extraordinary~~Company ~~General~~believes ~~Meeting~~that, as of ~~holders~~the date of this ~~Class A~~Current ~~ordinary~~Report ~~shares~~on ofForm 6-K, it satisfies the Shareholder Equity Rule for continued listing on the Nasdaq Capital Market. The Company is awaiting a formal compliance determination from the Staff and will provide an update upon receipt of such determination.

~~Attached~~The asabove ~~Exhibit~~descriptions ~~99.4~~of tothe ~~this~~SPA, ~~Report~~Warrant isand the ~~Form~~Note ofare ~~Proxy~~not ~~Card~~complete. toPlease berefer ~~mailed~~ to ~~holders~~the ofDecember ~~ordinary~~2024 ~~shares~~6-K offor the ~~Company~~full ~~for~~text ~~use~~of ~~in connection with~~ the ~~2025~~forms ~~Annual General Meeting~~ of ~~Shareholders~~such ~~of the Company~~documents.

~~Exhibits~~SIGNATURES

Exhibit No.		Description
99.1		Combined Notice and Proxy Statement of the Extraordinary General Meeting of holders of Class A ordinary shares of the Company and the 2025 Annual General Meeting of holders of ordinary shares of the Company, dated August 15, 2025, to be mailed to holders of Class A ordinary shares of the Company.
99.2		Notice and Proxy Statement of the 2025 Annual General Meeting of holders of ordinary shares of the Company, dated August 15, 2025, to be mailed to holders of Class B ordinary shares of the Company.
99.3		Form of Proxy Card to be mailed to holders of Class A ordinary shares of the Company for use in connection with the Extraordinary General Meeting of holders of Class A Ordinary Shares of the Company.
99.4		Form of Proxy Card to be mailed to holders of ordinary shares of the Company for use in connection with the 2025 Annual General Meeting of Shareholders of the Company.

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Golden Sun Health Technology Group Limited

By:	/s/ Xueyuan Weng
	Name:	Xueyuan Weng
	Title:	Chief Executive Officer

Date: August 25, 2025

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	Golden Sun Health Technology Group Limited
Date: August 15, 2025	By:	/s/ Xueyuan Weng
	Name:	Xueyuan Weng
	Title:	Chief Executive Officer

Filing Compare · Golden Sun Technology Group Ltd.